Miltenyi Biotec Honored for Leadership in Cell & Gene Therapy

Miltenyi Biotec received the Special Recognition Award for Pioneering Work in Cell & Gene Therapy at the BioSpectrum India Excellence Awards 2025. Recognized for its leadership in advancing cell and gene therapies, Miltenyi Biotec is transforming healthcare through innovative technologies and strengthening India's scientific landscape.

Miltenyi Biotec has earned the Special Recognition Award for Pioneering Work in Cell & Gene Therapy at the BioSpectrum India Excellence Awards 2025. This accolade, presented on December 5th at the India Habitat Centre in Delhi, highlights the company's innovative leadership in advancing cell and gene therapies.

The company is acknowledged for its role in accelerating translational research, empowering the scientific community, and driving personalized and regenerative medicine. Under the stewardship of Dr. Priya Kapoor G. Hingorani, Managing Director of Miltenyi Biotec India and Southeast Asia, the organization has established itself as a leader in cell and gene therapy space.

Miltenyi's contributions extend to technology-led solutions, enhancing diagnostics, vaccines, and digital health innovation. The company's recent collaboration with BRIC-THSTI and BIRAC to launch a practical 'Foundations of Cell and Gene Therapy' program marks another step in fortifying India's CGT capabilities, reducing reliance on foreign expertise, and propelling homegrown innovations.

(With inputs from agencies.)